Lavezzi, S. M. Et Al. 2019. Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial. PHARMACEUTICAL RESEARCH , vol.36, no.7 .

Lavezzi, S. M., de Jong, J., Neyens, M., Cramer, P., DEMİRKAN, F., Fraser, G., ... Bartlett, N.(2019). Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial. PHARMACEUTICAL RESEARCH , vol.36, no.7.

Lavezzi, Silvia Et Al. "Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial," PHARMACEUTICAL RESEARCH , vol.36, no.7, 2019

Lavezzi, Silvia M. Et Al. "Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial." PHARMACEUTICAL RESEARCH , vol.36, no.7, 2019

Lavezzi, S. M. Et Al. (2019) . "Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial." PHARMACEUTICAL RESEARCH , vol.36, no.7.

@article{article, author={Silvia Maria Lavezzi Et Al. }, title={Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial}, journal={PHARMACEUTICAL RESEARCH}, year=2019}